Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 942

Oncology Analytics processes $21m series B

McKesson Ventures and returning investor BlueCross BlueShield Venture Partners took part in a round that will support the cancer data provider's technology capabilities.

Nov 7, 2018

Molekule follows investors to $25m series B

Molekule, developer of a molecular-level air purifier, took its total funding to $39m in a Foundry Group-led round that did not include existing investor Foxconn.

Nov 7, 2018

Ambiq Micro ambles to $29m

The Arm and Fujitsu-backed low-power chip producer has now raised more than $135m altogether, after securing $29.1m from investors including EDBI.

Nov 7, 2018

Shape Security locks up $26m

JetBlue Technology Ventures and Singtel Innov8 have become cybersecurity software provider Shape's latest corporate backers, joining GV and HPE Pathfinder.

Nov 7, 2018

Vitamica energises seed round

Bristol spinout Vitamica has closed a seed round with the backing of University of Bristol Enterprise Fund II and Wyvern Seed Fund.

Nov 7, 2018

Tink Labs aims for $300m result

Hotel smartphone provider Tink Labs already counts Foxconn and TCL as investors but has reportedly approached travel and hospitality companies for funding at a $1.5bn valuation.

Nov 6, 2018

Dynamic Yield regenerates with $38m series D

Naver has joined Dynamic Yield’s series D round, which now totals $38m, three months after Union Group contributed to its initial close.

Nov 6, 2018

Opera shoots for StarMaker with $30m

Opera has injected $30m into entertainment-focused social media company StarMaker and secured an option to acquire a majority stake in 2020.

Nov 6, 2018

Hypothermia Devices fulfils $10.7m hype

UCLA spinout Hypothermia Devices graduated from a university-based accelerator in February and is now commercialising body temperature management devices for the medical and athletics markets.

Nov 6, 2018

Omeicos completes series C operation

Returning investor SMS Group took part in a $19.5m round for Omeicos that will fund the entry of its persistent atrial fibrillation drug candidate into a phase 2 trial.

Nov 6, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here